OBJECTIVE: Depressive symptoms (DS) have been associated with increased risk of cognitive decline. Our aim was to evaluate the longitudinal influence of DS on cognition in independent older people, accounting for the severity of white matter changes (WMC). METHODS: The LADIS (Leukoaraiosis And DISability in the elderly) prospective study evaluated the impact of WMC on the transition of independent older subjects into disability. Subjects were evaluated annually over a 3 year period with a comprehensive clinical and neuropsychological evaluation. Previous episodes of depression and current DS were assessed during each interview. Severity of DS was assessed using the self-rated 15 item Geriatric Depression Scale. A neuropsychological battery and clinical criteria for cognitive impairments were applied in all clinical visits, and cognitive compound measures were made based on neuropsychological results. MRI was performed at baseline and at year 3. RESULTS: 639 subjects were included (74.1 ± 5 years old, 55% women, 9.6 ± 3.8 years of schooling). Dementia was diagnosed in 90 patients and cognitive impairment not dementia in 147 patients at the last clinical evaluation. DS were an independent predictor of cognitive impairment (dementia and not dementia) during follow-up, independent of the effect of the severity of WMC, medial temporal lobe atrophy, age, education or global cognitive function at baseline. CONCLUSIONS: DS are associated with an increase risk of cognitive decline, independent of the effect of WMC, probably due to an additive or synergistic effect. In this context, DS probably represent a subtle ongoing organic dysfunction.
OBJECTIVE:Depressive symptoms (DS) have been associated with increased risk of cognitive decline. Our aim was to evaluate the longitudinal influence of DS on cognition in independent older people, accounting for the severity of white matter changes (WMC). METHODS: The LADIS (Leukoaraiosis And DISability in the elderly) prospective study evaluated the impact of WMC on the transition of independent older subjects into disability. Subjects were evaluated annually over a 3 year period with a comprehensive clinical and neuropsychological evaluation. Previous episodes of depression and current DS were assessed during each interview. Severity of DS was assessed using the self-rated 15 item Geriatric Depression Scale. A neuropsychological battery and clinical criteria for cognitive impairments were applied in all clinical visits, and cognitive compound measures were made based on neuropsychological results. MRI was performed at baseline and at year 3. RESULTS: 639 subjects were included (74.1 ± 5 years old, 55% women, 9.6 ± 3.8 years of schooling). Dementia was diagnosed in 90 patients and cognitive impairment not dementia in 147 patients at the last clinical evaluation. DS were an independent predictor of cognitive impairment (dementia and not dementia) during follow-up, independent of the effect of the severity of WMC, medial temporal lobe atrophy, age, education or global cognitive function at baseline. CONCLUSIONS: DS are associated with an increase risk of cognitive decline, independent of the effect of WMC, probably due to an additive or synergistic effect. In this context, DS probably represent a subtle ongoing organic dysfunction.
Authors: Meghan Riddle; Guy G Potter; Douglas R McQuoid; David C Steffens; John L Beyer; Warren D Taylor Journal: Am J Geriatr Psychiatry Date: 2017-03-28 Impact factor: 4.105
Authors: John M Ringman; Li-Jung Liang; Yan Zhou; Sitaram Vangala; Edmond Teng; Sarah Kremen; David Wharton; Alison Goate; Daniel S Marcus; Martin Farlow; Bernardino Ghetti; Eric McDade; Colin L Masters; Richard P Mayeux; Martin Rossor; Stephen Salloway; Peter R Schofield; Jeffrey L Cummings; Virginia Buckles; Randall Bateman; John C Morris Journal: Brain Date: 2015-02-15 Impact factor: 13.501
Authors: I W M van Uden; A M Tuladhar; H M van der Holst; E M C van Leijsen; A G W van Norden; K F de Laat; L C A Rutten-Jacobs; D G Norris; J A H R Claassen; E J van Dijk; R P C Kessels; F-E de Leeuw Journal: Hum Brain Mapp Date: 2015-10-15 Impact factor: 5.038
Authors: Dora Kanellopoulos; Paul Rosenberg; Lisa D Ravdin; Dalynah Maldonado; Nimra Jamil; Crystal Quinn; Dimitris N Kiosses Journal: Int Psychogeriatr Date: 2020-01-08 Impact factor: 3.878
Authors: Kavon Javaherian; Brianne M Newman; Hua Weng; Jason Hassenstab; Chengjie Xiong; Dean Coble; Anne M Fagan; Tammie Benzinger; John C Morris Journal: Alzheimer Dis Assoc Disord Date: 2019 Jan-Mar Impact factor: 2.703
Authors: Julie A Graziane; Joanne C Beer; Beth E Snitz; Chung-Chou H Chang; Mary Ganguli Journal: Am J Geriatr Psychiatry Date: 2015-10-22 Impact factor: 4.105
Authors: Lindsay R Clark; Rebecca L Koscik; Samantha L Allison; Sara E Berman; Derek Norton; Cynthia M Carlsson; Tobey J Betthauser; Barbara B Bendlin; Bradley T Christian; Nathaniel A Chin; Sanjay Asthana; Sterling C Johnson Journal: Alzheimers Dement Date: 2018-10-25 Impact factor: 21.566